CWM
NVAX icon

CIBC World Markets’s Novavax NVAX Stock Holding History

CIBC World Markets’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$116K Sell
18,449
-15,755
-46% -$104K ﹤0.01% 1380
2025
Q1 		$219K Buy
34,204
+19,778
+137% +$163K ﹤0.01% 1419
2024
Q4 		$116K Buy
+14,426
New +$139K ﹤0.01% 1200

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIBC World Markets's NVAX Position: Q2 2025 in Review

CIBC World Markets reduced its Novavax (NVAX) stake by 46% in Q2 2025, selling an estimated $104K and leaving 18,449 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1380.

CIBC World Markets first reported a position in NVAX in Q4 2024 and has held it in 3 quarters since. The position peaked at $219K in Q1 2025. 250 funds tracked by Wall St. Rank hold NVAX as of Q2 2025.

  • CIBC World Markets held 18,449 shares of Novavax worth $116K as of Q2 2025.
  • CIBC World Markets sold 15,755 Novavax shares in Q2 2025, an estimated $104K.
  • Novavax made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1380 holding.
  • CIBC World Markets first reported a position in Novavax in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Novavax position peaked at $219K in Q1 2025.
  • 250 funds tracked by Wall St. Rank held Novavax as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.